DICKINSON ANDREW D (EVP, Chief Financial Officer) sold 1.6% of their position (3K shares) of GILEAD SCIENCES, INC. on the open market
Open‑market sale worth $432.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/17/2026ACC: 0001310204-26-000012
Officer· EVP, Chief Financial Officer
Since Nov 2019
-3K
Net shares
Net seller
$432.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3K
Price / share
$144.23
Trade value
$432.69K
% of position
1.6%
3/16/2026
182.19K→179.19K
Total
Net shares
−3K
Net value
-$432.69K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/16/2026 | S · Sale | −3K | $144.23 | $432.69K | 1.6% | 182.19K | 179.19K |
| Total | −3K | -$432.69K | ||||||
Derivative Transactions0
No derivative transactions reported